Person Details

Home / About us / Board of Directors / Person Details

Giles Campion, MD

Giles Campion, MD, EVP, Head of R&D and Chief Medical Officer

Dr. Giles Campion joined Silence as Head of R&D and Chief Medical Officer in June 2019 and was appointed as an Executive Director in May 2020.

Dr. Campion is an expert in translational medicine and a highly experienced biotech and pharmaceutical professional across many therapeutic areas.  He has held senior global research and development roles in several large pharmaceutical, diagnostics and biotech companies, including GE Healthcare, Novartis and SmithKline Beecham. Dr. Campion served as Chief Medical Officer for Albumedix Ltd from January 2017 to July 2018. Prior to that, he served as Group Vice President, Neuromuscular Franchise at BioMarin Pharmaceutical Inc., or BioMarin, from February 2015 to March 2016, following BioMarin’s acquisition of Prosensa Holding N.V., or Prosensa.  He served as Chief Medical Officer and Senior Vice President of Research and Development at Prosensa from 2009 until its acquisition by BioMarin. He also served as medical advisor to MyoTherix Inc and is a co-founder of PepGen Ltd. 

Dr. Campion hold bachelors and doctorate degrees in medicine from the University of Bristol and is listed on the General Medical Council (UK) Specialist Register (Rheumatology).